Stephen A. Brassell, MD, FACS is a urologic oncologist with expertise in minimally invasive and robotic surgery and the management of complex urologic cancers. He is the medical director for urologic oncology, as well as medical director for St. Luke’s Cancer Institute in Boise.

During his Army career, Dr. Brassell completed an internship at Walter Reed Army Medical Center, followed by two years as battalion surgeon with the 10th Special Forces Group. While at Walter Reed he also served as a urologic oncologist, and was appointed the associate director of the Center for Prostate Disease Research, a multi-institutional national prostate cancer program, and assistant professor at the Uniformed Services University of the Health Sciences.

His military courses include airborne, flight surgery, dive medical, and cold weather/mountain warfare training. He has received a Meritorious Service Medal and Army Commendation Medal among other awards. Dr. Brassell chaired over 30 research studies and has published and presented over 70 articles in the urologic literature with a focus on urologic cancer.

• Robotic and open prostatectomy
• Robotic and open nephrectomy
• Robotic and open partial nephrectomy
• Robotic and open radical cystectomy
• Robotic and open partial cystectomy
• Robotic and open excision of retroperitoneal tumors
• Robotic and open adrenalectomy
• Robotic and open ureteral surgery
• Radical orchiectomy
• Retroperitoneal lymph node dissection
• Penectomy and organ sparing approaches to penile cancer
• Inguinal lymph node dissection
• Excision of any genitourinary malignancy

Tracey Busby, MD has special interest in pediatrics.

Robert Jackson, MD has special interest in the treatment of male infertility and men’s health issues such as erectile dysfunction, Peyronie’s disease, and hypogonadism. He has advanced training in the surgical management of erectile dysfunction and microsurgical techniques for varicocele repair and vasectomy reversal. He also treats a full spectrum of general urologic conditions, including voiding dysfunction, nephrolithiasis, and benign prostatic hyperplasia (BPH). Dr. Jackson uses minimally invasive treatments like Rezum™ and the UroLift® System to treat BPH as an alternative to drugs or more invasive therapies.

Dr. Jackson earned his bachelor’s degree from Brigham Young University and is a member of the American Urologic Association, American Society for Reproductive Medicine, and Sexual Medicine Society of North America.